Medidata
Search documents
Medidata Sees Strong Momentum with Key Customer Wins, Advances in CNS and Digital Therapeutics, and Expanded Market Leadership
Globenewswire· 2025-06-03 12:00
Core Insights - Medidata is advancing the life sciences industry through innovative, AI-powered solutions and a focus on patient, data, and study experiences [1][5][6] Group 1: Innovation and Partnerships - Medidata has launched the Site Insights Program to enhance site engagement and technology compliance in research [3] - The company has partnered with Cogstate to develop a comprehensive CNS trial experience, optimizing endpoint data quality [4] - Collaborations with Click Therapeutics aim to support patients beyond clinical trials with software-enhanced drugs [4][5] Group 2: Market Leadership - Medidata secured new enterprise agreements with a large pharmaceutical company, two top 10 biopharma manufacturers, and ICON, reinforcing its position as a trusted partner in clinical trials [5] - The company continues to set industry standards in clinical trial innovation, leveraging AI and machine learning to accelerate drug development [5] Group 3: Recognition and Awards - Medidata's Clinical Data Studio was recognized for improving data quality and accelerating study timelines, earning accolades from the Summit for Clinical Ops Executives [6] - The company was inducted into the Digital Health New York Hall of Fame, highlighting its commitment to innovation [6] - Medidata received the 2025 MedTech Breakthrough Award for Best Clinical Trial Technology Solution Provider due to its collaboration with Cogstate [6] Group 4: Leadership Strengthening - Medidata has enhanced its leadership team with new executive appointments and promotions to drive patient-centered innovation [7]
Medidata Debuts Protocol Optimization at ASCO, Leveraging AI to Transform the Study Experience
Globenewswire· 2025-05-29 12:00
Core Insights - Medidata has launched Medidata Protocol Optimization, a new solution aimed at improving clinical trial design and execution, which will be showcased at the ASCO 2025 conference [1][3] - The solution utilizes AI-driven predictive modeling and digital protocols to enhance trial performance, reduce patient and site burden, and lower costs associated with clinical trials [2] Company Overview - Medidata is a leading provider of clinical trial solutions, celebrating 25 years of innovation with over 36,000 trials and 11 million patients involved [4] - The company offers a comprehensive platform that supports more than 1 million registered users across approximately 2,300 customers, focusing on improving patient experiences and accelerating clinical breakthroughs [4] Industry Context - Oncology trials are noted for their complexity, often requiring more adjustments than other therapeutic areas, highlighting the need for solutions like Protocol Optimization to streamline processes [3]